Ambeed 大中华区 CN | ZH

中文 - ZH English - EN

Ambeed.cn

搜索

关键字搜索批量搜索

首页 收藏 购物车
首页 / 抑制剂/激动剂 / 代谢酶 / Transferase / Tipifarnib

替吡法尼 /Tipifarnib

货号：A412936 同义名： 提法法尼 / R115777;IND 58359

Tipifarnib是一种farnesyltransferase (Ftase) 的抑制剂，IC50为0.86 nM, 具有一定的抗肿瘤和抗寄生虫活性。

Tipifarnib 化学结构 CAS号：192185-72-1
Tipifarnib 化学结构
CAS号：192185-72-1
Tipifarnib 3D分子结构
CAS号：192185-72-1
Tipifarnib 化学结构 CAS号：192185-72-1
Tipifarnib 3D分子结构 CAS号：192185-72-1
规格 价格 库存 数量
50μL*10mM(DMSO) ￥139随货￥109 咨询
10mM*1mL(DMSO) ￥904 咨询
2mg ￥378 咨询
5mg ￥756 咨询
10mg ￥908 咨询
25mg ￥1814 咨询
50mg ￥2722 咨询
100mg ￥4082 咨询
1g ￥20588 咨询
购物车 收藏 询单

Tipifarnib 纯度/质量文件 产品仅供科研

货号：A412936 标准纯度：
批次查询： 批次纯度:

全球学术期刊中引用的产品

• ACS Appl. Nano Mater., 2025. Ambeed. [ A188026 ]
• Eur. J. Clin. Microbiol. Infect. Dis., 2025. Ambeed. [ A151161 ]
• JJC, 2025, 20(Special Issue)): 27-39. Ambeed. [ A713856 ]
• bioRxiv, 2025. Ambeed. [ A538667 , A714873 , A126729 , A126049 , A446054 ]
• Nature Communications, 2025, 16, 1871. Ambeed. [ A508148 ]
更多 >
产品名称 Transferase ↓ 其他靶点 纯度
Tipifarnib +++

FTase, IC50: 0.6 nM

 99%+
Tolcapone +

COMT, Ki: 30 nM

 99%+
Lonafarnib +++

K-ras-4B, IC50: 2.8 nM

H-ras, IC50: 1.9 nM

 99%+
(E)-Daporinad ++++

NMPRTase, Ki: 0.4 nM

 99%+
FTI-277 HCl ++++

FTase, IC50: 500 pM

 98%
A 922500 ++

human DGAT-1, IC50: 7 nM

mouse DGAT-1, IC50: 24 nM

 98%
Lomeguatrib ++

O6-alkylguanine-DNA-alkyltransferas, IC50: 5 nM

 99%+
PF-04620110 +

DGAT1, IC50: 19 nM

 99%
LB42708 +++

FTase (K-Ras), IC50: 0.8 nM

FTase (N-ras), IC50: 1.2 nM

 98%
GGTI298 Trifluoroacetate ✔ 98%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。

Tipifarnib 生物活性

靶点

  • Transferase

    FTase, IC50:0.6 nM

描述 Farnesylation is a posttranslational modification of proteins by which an isoprenyl group is added to a cysteine residue. In mammalian cells, newly synthesized proteins like Ras must be posttranslationally modified by farnesylation through farnesyl protein transferase to allow its proper membrane localization. Tipifarnib is a potent and selective farnesyl protein transferase (FPT) inhibitor with IC50 values of 0.86 nM and 7.9 nM for inhibition of the farnesylation of lamin B and K-RasB peptide substrates, respectively. Treatment with Tipifarnib at concentration ranging in 5-50nM for 3 days inhibited Ras (p21ras) processing in intact NIH 3T3 cells stably transfected with the T24 H-ras oncogene cells, observed by ratio of soluble and total particulate fractions. Tipifarnib exhibited a panel of human tumor cell lines of various tissue types with wide-type ras gene with IC50 values ranging in 2.7-111nM. Oral administration of Tipifarnib at dose ranging in 6.25–100 mg/kg, b.i.d, dose-dependently inhibited the growth of tumors bearing mutant H-ras, mutant K-ras, and wild-type ras genes in nude mice bearing s.c. tumors.

Tipifarnib 细胞研究

细胞系 浓度 检测类型 检测时间 活性说明 数据源
human 786-0 cell Growth inhibition assay Inhibition of human 786-0 cell growth in a cell viability assay, IC50=0.32173 μM SANGER
human 8505C cell Growth inhibition assay Inhibition of human 8505C cell growth in a cell viability assay, IC50=0.43109 μM SANGER
human A375 cell Growth inhibition assay Inhibition of human A375 cell growth in a cell viability assay, IC50=0.61648 μM SANGER
human A427 cell Growth inhibition assay Inhibition of human A427 cell growth in a cell viability assay, IC50=0.57917 μM SANGER

Tipifarnib 动物研究

Dose Mice: 3 mg/kg[3] (s.c.); 10 mg/kg[4] (i.p.); 100 mg/kg[5] (p.o.)
Administration s.c., i.p., p.o.

Tipifarnib 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT00076102 Neurofibromatosis 1 ... 展开 >> Neurofibroma, Plexiform 收起 << Phase 2 Completed - United States, Alabama ... 展开 >> University of Alabama Birmingham, Alabama, United States, 35233 United States, District of Columbia Childrens National Medical Center Washington, District of Columbia, United States, 20010 United States, Illinois Childrens Memorial Hospital, Chicago Chicago, Illinois, United States, 60614 United States, Maryland Johns Hopkins Oncology Center Baltimore, Maryland, United States, 21287 National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, Massachusetts Childrens Hospital, Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Mayo Clinic, Rochester Rochester, Minnesota, United States, 55905 United States, Missouri St. Louis Children's Hospital Saint Louis, Missouri, United States, 63110 United States, New York Beth Israel Medical Center New York, New York, United States, 10003 SUNY Upstate Medical University Syracuse, New York, United States, 13210 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Oregon Oregon Health Sciences University Portland, Oregon, United States, 97201-3098 United States, Pennsylvania Childrens Hospital, Philadelphia Philadelphia, Pennsylvania, United States, 19104 Childrens Hospital, Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Texas Texas Children's Hospital Houston, Texas, United States, 77030 收起 <<
NCT00076102 - Completed - -
NCT02845232 - Completed - France ... 展开 >> Hospices Civils de Lyon - Centre Hospitalier Lyon Sud, 165 Chemin du Grand Revoyet Pierre-benite, France, 69310 收起 <<

Tipifarnib 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.04mL

0.41mL

0.20mL

10.22mL

2.04mL

1.02mL

20.43mL

4.09mL

2.04mL

Tipifarnib 技术信息

CAS号192185-72-1
分子式C27H22Cl2N4O
分子量 489.396
别名 提法法尼 ;R115777;IND 58359;trade name Zarnestra;D03720;NSC702818;LX81
运输蓝冰
存储条件

In solvent -20°C:3-6个月-80°C:12个月

Pure form Inert atmosphere,Room Temperature

溶解方案

DMSO: 105 mg/mL(214.55 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液，再依次添加助溶剂：
——为保证实验结果的可靠性，澄清的储备液可以根据储存条件，适当保存；体内实验的工作液，建议现用现配，当天使用； 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比；如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的方式助溶
方案一
方案二
动物实验配方

IP 2% DMSO+water 0.5 mg/mL clear

PO 0.5% CMC-Na 18 mg/mL suspension

Tags: Tipifarnib | 192185-72-1 | IND 58359 | R115777 | IND58359 | IND-58359 | R115777 | R 115777 | R-115777 | FTase Inhibitor | Metabolic Enzyme/Protease | Farnesyl Transferase | 仅供科研使用 | AmBeed-信号通路专用抑制剂 | Tipifarnib 纯度/质量文件 | Tipifarnib 亚型比较 | Tipifarnib 生物活性 | Tipifarnib 细胞研究 | Tipifarnib 动物研究 | Tipifarnib 临床数据 | Tipifarnib 实验方案 | Tipifarnib 技术信息

Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
    • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质用途提供服务。

    尊敬的 Ambeed 客户您好，
    请您选择所在区域，我们将转接对应客服为您服务！

    热门区域

    A

    B

    C

    F

    G

    H

    J

    L

    N

    Q

    S

    T

    X

    Y

    Z

    热 A B C F G H J L N Q S T X Y Z